Answers are grounded in this paper and cite their sources.
Trial paper on avacopan's regulatory approval in vasculitis has been retracted, highlighting ongoing FDA scrutiny.
drug avacopan, branded as Tavneos, to gain regulatory approval has been retracted by the New England Journal of Medicine (NEJM).
No takes yet. Share an insight, caveat, or question.
Chris Baraniuk (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: